[96a5a0]: / output / allTrials / identified / NCT02070120_identified.json

Download this file

583 lines (583 with data), 25.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
{
"info": {
"nct_id": "NCT02070120",
"official_title": "CALIBER - A Phase II Randomised Feasibility Study of Chemoresection and Surgical Management in Low Risk Non Muscle Invasive Bladder Cancer",
"inclusion_criteria": "* Written informed consent\n* NMIBC recurrence following original diagnosis of low risk NMIBC (defined as Ta G1 or Ta G2 (Ta low grade) with a risk of recurrence score of ≤6 using EORTC risk tables\n* Histologically confirmed Transitional-cell carcinoma (TCC) at original diagnosis\n* Aged 16 or over\n* Satisfactory pre-treatment haematology values and serum creatinine < 1.5 x Upper Limit of Normal (ULN)\n* Negative pregnancy test for women of child-bearing potential\nHealthy volunteers allowed\nMust have minimum age of 16 Years",
"exclusion_criteria": "* Any history of: grade 3/high grade or ≥T1 transitional cell carcinoma, concomitant carcinoma in situ, more than 7 tumours at one diagnosis or more than 1 recurrence per year since initial diagnosis or in the past five years, whichever is shorter\n* Any history of histologically confirmed non-TCC bladder cancer\n* Trial entry recurrence identified within 11.5 months of the date of the original diagnosis\n* Any prior treatment of the trial entry recurrence (including biopsy)\n* Previous MMC chemotherapy other than a single instillation at diagnostic surgery\n* Known allergy to MMC\n* Carcinoma involving the prostatic urethra or upper urinary tract (participants should have had imaging of the upper urinary tract within 2 years prior to randomisation)\n* Known or suspected reduced bladder capacity (<100ml)\n* Significant bleeding disorder\n* Female patients who are breast-feeding or are of childbearing potential and unwilling or unable to use adequate non-hormonal contraception. Male patients should also use contraception if sexually active.\n* Active or intractable urinary tract infection\n* Urethral stricture or anything impeding the insertion of a catheter\n* Large narrow neck diverticula\n* Significant urinary incontinence\n* Any other conditions that in the Principal Investigator's opinion would contraindicate protocol treatment\n* Unable or unwilling to comply with study procedures or follow up schedule",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Written informed consent",
"criterions": [
{
"exact_snippets": "Written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "form",
"expected_value": "written"
}
]
}
]
},
{
"line": "* NMIBC recurrence following original diagnosis of low risk NMIBC (defined as Ta G1 or Ta G2 (Ta low grade) with a risk of recurrence score of ≤6 using EORTC risk tables",
"criterions": [
{
"exact_snippets": "NMIBC recurrence following original diagnosis of low risk NMIBC",
"criterion": "NMIBC recurrence",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "following original diagnosis of low risk NMIBC"
}
]
},
{
"exact_snippets": "original diagnosis of low risk NMIBC (defined as Ta G1 or Ta G2 (Ta low grade)",
"criterion": "original diagnosis of low risk NMIBC",
"requirements": [
{
"requirement_type": "definition",
"expected_value": [
"Ta G1",
"Ta G2",
"Ta low grade"
]
}
]
},
{
"exact_snippets": "risk of recurrence score of ≤6 using EORTC risk tables",
"criterion": "risk of recurrence score",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "EORTC risk tables"
}
}
]
}
]
},
{
"line": "* Histologically confirmed Transitional-cell carcinoma (TCC) at original diagnosis",
"criterions": [
{
"exact_snippets": "Histologically confirmed Transitional-cell carcinoma (TCC)",
"criterion": "Transitional-cell carcinoma (TCC)",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": "histologically confirmed"
}
]
},
{
"exact_snippets": "original diagnosis",
"criterion": "original diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Aged 16 or over",
"criterions": [
{
"exact_snippets": "Aged 16 or over",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 16,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Satisfactory pre-treatment haematology values and serum creatinine < 1.5 x Upper Limit of Normal (ULN)",
"criterions": [
{
"exact_snippets": "Satisfactory pre-treatment haematology values",
"criterion": "pre-treatment haematology values",
"requirements": [
{
"requirement_type": "satisfaction",
"expected_value": "satisfactory"
}
]
},
{
"exact_snippets": "serum creatinine < 1.5 x Upper Limit of Normal (ULN)",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 1.5,
"unit": "x ULN"
}
}
]
}
]
},
{
"line": "* Negative pregnancy test for women of child-bearing potential",
"criterions": [
{
"exact_snippets": "Negative pregnancy test for women of child-bearing potential",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 16 Years",
"criterions": [
{
"exact_snippets": "minimum age of 16 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 16,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Any history of: grade 3/high grade or ≥T1 transitional cell carcinoma, concomitant carcinoma in situ, more than 7 tumours at one diagnosis or more than 1 recurrence per year since initial diagnosis or in the past five years, whichever is shorter",
"criterions": [
{
"exact_snippets": "Any history of: grade 3/high grade or ≥T1 transitional cell carcinoma",
"criterion": "transitional cell carcinoma",
"requirements": [
{
"requirement_type": "grade",
"expected_value": [
"grade 3",
"high grade"
]
},
{
"requirement_type": "stage",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "T"
}
}
]
},
{
"exact_snippets": "Any history of: ... concomitant carcinoma in situ",
"criterion": "carcinoma in situ",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Any history of: ... more than 7 tumours at one diagnosis",
"criterion": "number of tumours at one diagnosis",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 7,
"unit": "tumours"
}
}
]
},
{
"exact_snippets": "Any history of: ... more than 1 recurrence per year since initial diagnosis or in the past five years, whichever is shorter",
"criterion": "recurrence rate",
"requirements": [
{
"requirement_type": "frequency",
"expected_value": {
"operator": ">",
"value": 1,
"unit": "recurrences per year"
}
}
]
}
]
},
{
"line": "* Any history of histologically confirmed non-TCC bladder cancer",
"criterions": [
{
"exact_snippets": "Any history of histologically confirmed non-TCC bladder cancer",
"criterion": "non-TCC bladder cancer",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "confirmation",
"expected_value": "histologically"
}
]
}
]
},
{
"line": "* Trial entry recurrence identified within 11.5 months of the date of the original diagnosis",
"criterions": [
{
"exact_snippets": "recurrence identified within 11.5 months of the date of the original diagnosis",
"criterion": "recurrence",
"requirements": [
{
"requirement_type": "time since original diagnosis",
"expected_value": {
"operator": "<=",
"value": 11.5,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Any prior treatment of the trial entry recurrence (including biopsy)",
"criterions": [
{
"exact_snippets": "Any prior treatment of the trial entry recurrence",
"criterion": "prior treatment of trial entry recurrence",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Previous MMC chemotherapy other than a single instillation at diagnostic surgery",
"criterions": [
{
"exact_snippets": "Previous MMC chemotherapy other than a single instillation at diagnostic surgery",
"criterion": "MMC chemotherapy",
"requirements": [
{
"requirement_type": "previous treatment",
"expected_value": true
},
{
"requirement_type": "quantity",
"expected_value": "other than a single instillation at diagnostic surgery"
}
]
}
]
},
{
"line": "* Known allergy to MMC",
"criterions": [
{
"exact_snippets": "Known allergy to MMC",
"criterion": "allergy to MMC",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Carcinoma involving the prostatic urethra or upper urinary tract (participants should have had imaging of the upper urinary tract within 2 years prior to randomisation)",
"criterions": [
{
"exact_snippets": "Carcinoma involving the prostatic urethra",
"criterion": "carcinoma in prostatic urethra",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Carcinoma involving the ... upper urinary tract",
"criterion": "carcinoma in upper urinary tract",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "imaging of the upper urinary tract within 2 years prior to randomisation",
"criterion": "imaging of upper urinary tract",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within 2 years prior to randomisation"
}
]
}
]
},
{
"line": "* Known or suspected reduced bladder capacity (<100ml)",
"criterions": [
{
"exact_snippets": "Known or suspected reduced bladder capacity (<100ml)",
"criterion": "bladder capacity",
"requirements": [
{
"requirement_type": "capacity",
"expected_value": {
"operator": "<",
"value": 100,
"unit": "ml"
}
}
]
}
]
},
{
"line": "* Significant bleeding disorder",
"criterions": [
{
"exact_snippets": "Significant bleeding disorder",
"criterion": "bleeding disorder",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Female patients who are breast-feeding or are of childbearing potential and unwilling or unable to use adequate non-hormonal contraception. Male patients should also use contraception if sexually active.",
"criterions": [
{
"exact_snippets": "Female patients who are breast-feeding",
"criterion": "breast-feeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Female patients ... of childbearing potential",
"criterion": "childbearing potential",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Female patients ... unwilling or unable to use adequate non-hormonal contraception",
"criterion": "use of non-hormonal contraception",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
},
{
"requirement_type": "ability",
"expected_value": true
}
]
},
{
"exact_snippets": "Male patients should also use contraception if sexually active",
"criterion": "use of contraception",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Active or intractable urinary tract infection",
"criterions": [
{
"exact_snippets": "Active or intractable urinary tract infection",
"criterion": "urinary tract infection",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"active",
"intractable"
]
}
]
}
]
},
{
"line": "* Urethral stricture or anything impeding the insertion of a catheter",
"criterions": [
{
"exact_snippets": "Urethral stricture",
"criterion": "urethral stricture",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "anything impeding the insertion of a catheter",
"criterion": "impediment to catheter insertion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Large narrow neck diverticula",
"criterions": [
{
"exact_snippets": "Large narrow neck diverticula",
"criterion": "diverticula",
"requirements": [
{
"requirement_type": "size",
"expected_value": "large"
},
{
"requirement_type": "neck type",
"expected_value": "narrow"
}
]
}
]
},
{
"line": "* Significant urinary incontinence",
"criterions": [
{
"exact_snippets": "Significant urinary incontinence",
"criterion": "urinary incontinence",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Any other conditions that in the Principal Investigator's opinion would contraindicate protocol treatment",
"criterions": [
{
"exact_snippets": "Any other conditions ... contraindicate protocol treatment",
"criterion": "other conditions",
"requirements": [
{
"requirement_type": "contraindication",
"expected_value": true
}
]
}
]
},
{
"line": "* Unable or unwilling to comply with study procedures or follow up schedule",
"criterions": [
{
"exact_snippets": "Unable or unwilling to comply with study procedures",
"criterion": "compliance with study procedures",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
},
{
"exact_snippets": "Unable or unwilling to ... follow up schedule",
"criterion": "compliance with follow up schedule",
"requirements": [
{
"requirement_type": "willingness",
"expected_value": true
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}